AbbVie Inc. stock outperforms competitors on strong trading day
Market Watch· 4 days agoShares of AbbVie Inc. rallied 1.67% to $140.34 Monday, on what proved to be an all-around mixed...
AbbVie (NYSE:ABBV) Price Target Cut to $160.00
ETF DAILY NEWS· 1 day agoAbbVie (NYSE:ABBV – Get Rating) had its price target dropped by equities research analysts at Barclays to $160.00 in a research note issued to investors on Tuesday, Stock ...
In the Weeds? Humira “Patent Thicket” Isn’t an Antitrust Violation
The National Law Review· 20 hours agoThe US Court of Appeals for the Seventh Circuit affirmed that welfare benefit plans that bought the...
Is AbbVie Stock A Buy Or A Sell With Humira Rivals Looming?
Investor's Business Daily· 2 days agoAbbVie stock is under pressure after the company posted a mixed second-quarter report that relied...
3 Reasons Why AbbVie Stock Could Be Approaching a Make or Break Moment | The Motley Fool
The Motley Fool· 7 days agoAfter the market's tepid reception to AbbVie's (ABBV -0.63%) latest earnings report on July 29, the...
Looking At AbbVie's Recent Whale Trades
Benzinga· 7 days agoA whale with a lot of money to spend has taken a noticeably bearish stance on AbbVie. Looking at options history for AbbVie (NYSE:ABBV) we detected 12 strange trades.
Redditors are Buying These 10 Dividend ETFs in August
Insider Monkey via Yahoo Finance· 16 hours agoIn this article, we discuss 10 dividend ETFs that Redditors are buying in August. You can skip our...
Amgen Stock: Chemocentryx Buyout Papers Over Cracks In Long-Term Outlook
Seeking Alpha· 16 hours agoFurthermore, all of these companies - what I like to term as the "Big 8" US Pharmas - in order of...
3 Unstoppable Dividend Stocks to Buy in August | The Motley Fool
The Motley Fool· 6 days agoThe differentiator is how strong the underlying businesses are that make the dividends possible....
Facing price controls, pharma industry cranks up heat on Congress
CNN.com· 3 hours agoFor decades, the drug industry has yelled bloody murder each time Congress considered a regulatory...